Related Experiment Video

Updated: May 18, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Interventional cardiology audit report for 2011

L Baker1

  • 1Quality Department, Epworth HealthCare, Epworth Hospital, Melbourne, Victoria, Australia. Leonie.Baker@epworth.org.au

Internal Medicine Journal
|October 6, 2012
PubMed

Insights

In 2011, percutaneous coronary interventions (PCI) were performed in 658 patients, primarily for acute coronary syndrome. Drug-eluting stents and balloon angioplasty were common, with high procedural success and low major adverse cardiac events.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Structural Heart Disease

Background:

  • In 2011, interventional cardiology procedures were analyzed.
  • Over 60% of patients undergoing percutaneous coronary intervention (PCI) presented with acute coronary syndrome.
  • Transcatheter aortic valve implantation (TAVI) procedures doubled compared to 2010.

Purpose of the Study:

  • To report on the outcomes of PCI and TAVI procedures in 2011.
  • To assess the success rates and adverse events associated with PCI.
  • To highlight the increasing trend in TAVI for structural heart disease.

Main Methods:

  • Retrospective analysis of 658 PCI cases.
  • Review of procedural success rates and major adverse cardiac events (MACE).
  • Analysis of 25 Core Valve procedures (TAVI).

Main Results:

  • Procedural success for PCI was 93.3% with a 3.6% MACE rate.
  • Mortality rate for PCI was 0.5%.
  • Drug-eluting stents were used in 93% of PCI procedures.

Conclusions:

  • PCI procedures in 2011 demonstrated high success and safety.
  • The significant increase in TAVI cases indicates a shift in structural heart disease management.
  • Interventional cardiology continues to evolve with advanced device utilization.

More Related Videos

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...